Balancing potential risks and benefits of adjunctive use of aripiprazole with risperidone for the treatment of schizophrenia: Reply to Dr Deng et al

Hiroyuki Uchida, David C. Mamo

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)136-137
Number of pages2
JournalJournal of clinical psychopharmacology
Issue number1
Publication statusPublished - 2011 Feb 1

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this